AI assistant
Sending…
Gossamer Bio, Inc. — Director's Dealing 2019
Feb 12, 2019
32603_dirs_2019-02-12_41f1576b-0606-498d-931e-739089652701.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2019-02-12
Reporting Person: Cox Russell J. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-12 | Common Stock | P | 7200 | $16.00 | Acquired | 7200 | Direct |
More from Gossamer Bio, Inc.
Capital/Financing Update
2026
Jun 4
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Capital/Financing Update
2026
Jun 2
Proxy Solicitation & Information Statement
2026
May 18
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Delisting Announcement
2026
Apr 9
Major Shareholding Notification
2026
Mar 27